相关实验视频

Updated: Jun 14, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

作为抗癌药物重新利用特兰胺酸:系统性审查和元分析

Karoline Assifuah Kristjansen^1,2, Nulvin Djebbara-Bozo³, Kumanan Rune Nanthan⁴

¹Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. karoline_kristjansen@clin.au.dk.

Journal of cancer research and clinical oncology

|May 9, 2025

概括

药物再利用为癌症提供了新的治疗方法. 在临床前的研究中,特兰胺酸 (TXA) 显示出有希望的结果,减少瘤生长,活力和侵入性,这表明它有可能作为一种重新定位的癌症药物.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
药物重用药物重用

背景情况:

药物重新定位是发现新型癌症治疗方法的可行策略.
胺酸 (TXA) 是一种抗纤维解质剂,影响瘤进展至关重要的途径,包括扩散,血管生成和炎症.

研究的目的:

系统地评估特兰胺酸 (TXA) 的抗癌作用.
通过体外,动物和临床研究来评估TXA作为重用癌症药物的潜力.

主要方法:

进行了符合PRISMA的系统审查和元分析.
在主要数据库 (MEDLINE,EMBASE,科学网,柯克兰图书馆) 进行文献搜索.
包括体外,动物和TXA或epsilon-aminocaproic acid (EACA) 的临床研究;低风险偏差研究的批判性评估和元分析.

主要成果:

包括 38 篇文章,包括 41 篇实验室, 34 篇动物和 7 篇临床研究.
对9项动物研究的元分析表明,TXA治疗显著减少了瘤生长 (SMD-1.0,p=0.0002).
实验室研究始终显示,TXA暴露后瘤细胞增殖,活力和侵入性降低;临床研究具有高偏差.

结论:

特兰胺酸 (TXA) 显示出作为一种重新定位的抗癌剂的潜力.
临床前证据 (体外和动物模型) 表明,TXA可以降低瘤生长,活力和侵入性.
由于现有人类研究中的偏见,需要进一步进行高质量的临床试验.

关键词:

抗癌剂是一种抗癌剂.抗纤维素分析剂抗纤维素分析剂癌症治疗治疗癌症治疗药物重新定位是药物重新定位.系统性审查系统性审查特兰克萨姆酸是什么意思

更多相关视频

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...